CN101340926A - 治疗重症肌无力的方法 - Google Patents
治疗重症肌无力的方法 Download PDFInfo
- Publication number
- CN101340926A CN101340926A CNA2006800376672A CN200680037667A CN101340926A CN 101340926 A CN101340926 A CN 101340926A CN A2006800376672 A CNA2006800376672 A CN A2006800376672A CN 200680037667 A CN200680037667 A CN 200680037667A CN 101340926 A CN101340926 A CN 101340926A
- Authority
- CN
- China
- Prior art keywords
- purposes
- medicament
- complement
- myasthenia gravis
- conjunction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1604—Chisels; Rongeurs; Punches; Stamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1613—Component parts
- A61B17/1631—Special drive shafts, e.g. flexible shafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1662—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body
- A61B17/1671—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body for the spine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/4611—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of spinal prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1613—Component parts
- A61B17/1633—Sleeves, i.e. non-rotating parts surrounding the bit shaft, e.g. the sleeve forming a single unit with the bit shaft
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dentistry (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Surgical Instruments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (20)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0518443.7A GB0518443D0 (en) | 2005-09-09 | 2005-09-09 | Method of treating myasthenia gravis |
GB0518443.7 | 2005-09-09 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310352827.4A Division CN103505721A (zh) | 2005-09-09 | 2006-09-05 | 治疗重症肌无力的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101340926A true CN101340926A (zh) | 2009-01-07 |
Family
ID=35221219
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310352827.4A Pending CN103505721A (zh) | 2005-09-09 | 2006-09-05 | 治疗重症肌无力的方法 |
CNA2006800376672A Pending CN101340926A (zh) | 2005-09-09 | 2006-09-05 | 治疗重症肌无力的方法 |
CN202080073067.1A Pending CN114555013A (zh) | 2005-09-09 | 2020-10-19 | 医疗进入装置 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310352827.4A Pending CN103505721A (zh) | 2005-09-09 | 2006-09-05 | 治疗重症肌无力的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080073067.1A Pending CN114555013A (zh) | 2005-09-09 | 2020-10-19 | 医疗进入装置 |
Country Status (11)
Country | Link |
---|---|
US (3) | US9192648B2 (zh) |
EP (2) | EP1931372B1 (zh) |
JP (1) | JP5254792B2 (zh) |
CN (3) | CN103505721A (zh) |
AU (1) | AU2006288985B2 (zh) |
CA (1) | CA2621697C (zh) |
DK (1) | DK1931372T3 (zh) |
ES (1) | ES2542853T3 (zh) |
GB (1) | GB0518443D0 (zh) |
NZ (1) | NZ566789A (zh) |
WO (2) | WO2007028968A1 (zh) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0518443D0 (en) | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
GB0802116D0 (en) * | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
NZ614351A (en) * | 2008-11-10 | 2015-05-29 | Alexion Pharma Inc | Methods and compositions for treating complement-associated disorders |
PL2521562T3 (pl) | 2010-01-08 | 2020-04-30 | Volution Immuno Pharmaceuticals Sa | Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych |
EP2720708A4 (en) | 2011-06-20 | 2015-10-14 | Univ Saint Louis | AIMING AT THE NEUROMUSCULAR END PLATE FOR TREATMENT PURPOSES |
AU2012272706B2 (en) | 2011-06-22 | 2017-07-06 | Apellis Pharmaceuticals, Inc. | Methods of treating chronic disorders with complement inhibitors |
LT2817329T (lt) | 2012-02-20 | 2019-04-10 | Swedish Orphan Biovitrum Ab (Publ) | Polipeptidai, prisijungiantys prie žmogaus komplemento c5 |
SG11201602679VA (en) | 2013-08-28 | 2016-05-30 | Swedish Orphan Biovitrum Ab Publ | Stable polypeptides binding to human complement c5 |
PT3039033T (pt) | 2013-08-28 | 2019-09-06 | Affibody Ab | Polipéptidos de ligação com um scaffold mutado |
GB201410116D0 (en) * | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
WO2016198133A1 (en) * | 2015-06-08 | 2016-12-15 | Volution Immuno Pharmaceuticals Sa | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
GB201602802D0 (en) | 2016-02-17 | 2016-03-30 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
KR20190008225A (ko) * | 2016-05-13 | 2019-01-23 | 델노바 인코퍼레이티드 | 화학적 신경차단으로 인한 부작용의 치료 |
WO2017218515A1 (en) | 2016-06-14 | 2017-12-21 | Regeneron Pharmaceuticals, Inc. | Anti-c5 antibodies and uses thereof |
US20200054611A1 (en) | 2017-01-09 | 2020-02-20 | Gt Biopharma, Inc. | Use and composition for treating myasthenia gravis and other myasthenic syndromes |
US20200000756A1 (en) * | 2017-01-24 | 2020-01-02 | Gt Biopharma, Inc. | Neostigmine combination and compositions |
US11730792B2 (en) | 2017-04-21 | 2023-08-22 | Volution Immuno Pharmaceuticals Sa | Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA) |
GB201706406D0 (en) | 2017-04-21 | 2017-06-07 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
CA3083113A1 (en) | 2017-12-13 | 2019-06-20 | Regeneron Pharmaceuticals, Inc. | Anti-c5 antibody combinations and uses thereof |
WO2020053206A1 (en) | 2018-09-10 | 2020-03-19 | Volution Immuno Pharmaceuticals Sa | Coversin for use in the treatment of rheumatic diseases |
GB201905810D0 (en) | 2019-04-25 | 2019-06-05 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
EP4034237A1 (en) | 2019-09-27 | 2022-08-03 | Volution Immuno Pharmaceuticals SA | Method of treatment of hematopoietic stem cell transplant associated thrombotic microangiopathy (hsct-tma) |
WO2024039740A2 (en) * | 2022-08-16 | 2024-02-22 | Gro Biosciences Inc. | Polypeptide compositions containing non-standard glycan stub amino acids and methods of making and uses thereof |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041389A (en) * | 1986-01-06 | 1991-08-20 | The Salk Institute For Biological Studies | Assays for myasthenia gravis |
WO1993017099A1 (en) | 1992-02-27 | 1993-09-02 | Merck & Co., Inc. | Protein for inhibiting collagen-stimulated platelet aggregation |
US5456909A (en) * | 1992-08-07 | 1995-10-10 | T Cell Sciences, Inc. | Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo |
US6103748A (en) * | 1998-06-19 | 2000-08-15 | Bryan; Thomas B. | Method of treating an autoimmune disorder |
US7884066B2 (en) | 1999-10-05 | 2011-02-08 | The Regents Of The University Of California | NELL-1 enhanced bone mineralization |
JP2005530719A (ja) * | 2002-03-29 | 2005-10-13 | ニューロジェン コーポレーション | 病原性炎症要素を有する状態の治療のための組み合わせ療法 |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
NZ544163A (en) | 2003-06-02 | 2009-06-26 | Evolutec Ltd | Complement inhibitors |
EP1667702A2 (en) * | 2003-09-10 | 2006-06-14 | Baxter International Inc., Baxter Healthcare Corp. | Peptides that inhibit complement activation |
JP2007507543A (ja) * | 2003-10-06 | 2007-03-29 | セダーズ−シナイ メディカル センター | 樹状細胞治療によって誘導されるt細胞アネルギーを予防するためのcox−2インヒビターの使用 |
HUE038239T2 (hu) | 2004-02-12 | 2018-10-29 | Archemix Llc | Komplementrendszerrel összefüggõ rendellenességek kezelésében alkalmazható aptamer terapeutikumok |
GB0518443D0 (en) | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
AU2006341592A1 (en) | 2006-04-12 | 2007-10-18 | Biocryst Pharmaceuticals, Inc. | Intramuscular antiviral treatments |
PL2061501T3 (pl) | 2006-09-08 | 2016-01-29 | Volution Immuno Pharmaceuticals Sa | Sposób leczenia zaburzeń oddechowych |
GB0617734D0 (en) | 2006-09-08 | 2006-10-18 | Evolutec Ltd | Method of treating peripheral nerve disorders |
US20080114055A1 (en) * | 2006-11-10 | 2008-05-15 | Zoltan Laboratories Llc | Thioxanthone Compounds to Reverse Weight Loss |
GB0802116D0 (en) | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
US8852201B2 (en) * | 2009-03-30 | 2014-10-07 | Arthrex, Inc. | Microfracture instrument |
WO2011060077A1 (en) * | 2009-11-10 | 2011-05-19 | Spine View, Inc. | Angled grinder |
US8840668B1 (en) | 2009-11-11 | 2014-09-23 | Nuvasive, Inc. | Spinal implants, instruments and related methods |
US8740983B1 (en) | 2009-11-11 | 2014-06-03 | Nuvasive, Inc. | Spinal fusion implants and related methods |
US8562592B2 (en) * | 2010-05-07 | 2013-10-22 | Ethicon Endo-Surgery, Inc. | Compound angle laparoscopic methods and devices |
US20120071876A1 (en) * | 2010-09-17 | 2012-03-22 | Stoll E Jordan | Microfracture awl |
AU2014306235A1 (en) * | 2013-08-05 | 2016-03-10 | Scott L. Blumenthal | Vertebral endplate apparatus and method |
US10172650B2 (en) * | 2014-10-21 | 2019-01-08 | Warsaw Orthopedic, Inc. | Spinal implant system and method |
US10265194B2 (en) * | 2015-04-01 | 2019-04-23 | Zimmer Biomet Spine, Inc. | Insertion instrument with articulating wrist |
-
2005
- 2005-09-09 GB GBGB0518443.7A patent/GB0518443D0/en not_active Ceased
-
2006
- 2006-09-05 EP EP06779285.3A patent/EP1931372B1/en active Active
- 2006-09-05 JP JP2008529680A patent/JP5254792B2/ja active Active
- 2006-09-05 US US11/991,690 patent/US9192648B2/en active Active
- 2006-09-05 ES ES06779285.3T patent/ES2542853T3/es active Active
- 2006-09-05 WO PCT/GB2006/003265 patent/WO2007028968A1/en active Application Filing
- 2006-09-05 CN CN201310352827.4A patent/CN103505721A/zh active Pending
- 2006-09-05 CN CNA2006800376672A patent/CN101340926A/zh active Pending
- 2006-09-05 CA CA2621697A patent/CA2621697C/en active Active
- 2006-09-05 AU AU2006288985A patent/AU2006288985B2/en active Active
- 2006-09-05 NZ NZ566789A patent/NZ566789A/en not_active IP Right Cessation
- 2006-09-05 DK DK06779285.3T patent/DK1931372T3/en active
-
2015
- 2015-10-20 US US14/918,432 patent/US20160166640A1/en not_active Abandoned
-
2019
- 2019-10-25 US US16/663,655 patent/US20200282018A1/en active Pending
-
2020
- 2020-10-19 EP EP20878690.5A patent/EP4048171A4/en active Pending
- 2020-10-19 WO PCT/US2020/056286 patent/WO2021080910A1/en unknown
- 2020-10-19 CN CN202080073067.1A patent/CN114555013A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2006288985A1 (en) | 2007-03-15 |
CA2621697A1 (en) | 2007-03-15 |
GB0518443D0 (en) | 2005-10-19 |
CN114555013A (zh) | 2022-05-27 |
CA2621697C (en) | 2017-08-29 |
CN103505721A (zh) | 2014-01-15 |
EP4048171A1 (en) | 2022-08-31 |
JP2009508819A (ja) | 2009-03-05 |
US9192648B2 (en) | 2015-11-24 |
ES2542853T3 (es) | 2015-08-12 |
EP1931372B1 (en) | 2015-04-29 |
WO2021080910A1 (en) | 2021-04-29 |
DK1931372T3 (en) | 2015-05-26 |
NZ566789A (en) | 2011-11-25 |
EP1931372A1 (en) | 2008-06-18 |
JP5254792B2 (ja) | 2013-08-07 |
WO2007028968A9 (en) | 2008-06-12 |
WO2007028968A1 (en) | 2007-03-15 |
US20200282018A1 (en) | 2020-09-10 |
US20160166640A1 (en) | 2016-06-16 |
EP4048171A4 (en) | 2023-11-22 |
US20090209459A1 (en) | 2009-08-20 |
AU2006288985B2 (en) | 2011-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101340926A (zh) | 治疗重症肌无力的方法 | |
US20220249608A1 (en) | Method of Treating Peripheral Nerve Disorders | |
AU2007293241B2 (en) | Method of treating respiratory disorders | |
RU2700932C2 (ru) | Ornithodoros moubata игибитор комплемента, предназначенный для лечения опосредованных комплементом заболеваний пациента с полиморфизмом с5 комплемента | |
AU2011204483A1 (en) | EV576 for use in the treatment of viral infections of the respiratory tract | |
EP3302519B1 (en) | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease | |
DK2061501T3 (en) | METHOD OF TREATING RESPIRATORY DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: VARLEIGH LTD. Free format text: FORMER OWNER: EVOLUTEC LTD. Effective date: 20130407 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: British Isles Applicant after: Volution Immuno Pharmaceuticals S.A. Address before: British Isles Applicant before: Vanessa Co.,Ltd. Address after: University of Manchester Applicant after: EVOLUTEC Ltd. Address before: Burke County, England Applicant before: EVOLUTEC Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: VARLEIGH LTD. TO: VARLEIGH IMMUNO PHARMACEUTICALS LTD. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130407 Address after: British Isles Applicant after: Vanessa Co.,Ltd. Address before: University of Manchester Applicant before: EVOLUTEC Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090107 |